期刊文献+

人巨细胞病毒pp65蛋白的原核表达及免疫学特性分析 被引量:1

Expression and Purification of Human Cytomegalovirus Tegument Protein pp65 and Analysis of its Immunologic Characteristics
下载PDF
导出
摘要 目的应用生物工程方法研制人巨细胞病毒包膜蛋白pp65,并行相应抗体制备的探讨性研究。方法利用DNA重组技术,以HCMVAD169病毒株基因组为模板,通过PCR克隆HCMVpp65基因。以pET32a(+)为表达载体,构建重组质粒,并在E.Coli(DE3plys)中诱导表达。然后经柱层析获得纯化蛋白,由蛋白质印迹法验证蛋白的特异性。最后,免疫小鼠获取抗血清,检测抗体产生的效价。结果重组质粒经测序与Genebank序列一致,转染的细菌能高效表达目的蛋白,纯化后的蛋白能与已知单克隆抗体结合,免疫后的小鼠抗血清能同时识别重组蛋白和病毒抗原。结论重组表达的HCMVpp65全蛋白经纯化获得较高纯度,且保留良好的免疫原特性。为HCMV感染诊断用单克隆抗体的研制奠定了基础,并为HCMV感染的免疫诊断和治疗提供了新的研究方向。 Objective: To express and purify Human Cytomegalovirus tegument phosphoprotein pp65 in prokaryotic expression system. Methods: Primers designed based on the gene sequence and the gene of pp65 amplified by PCR was cloned into the vector pet32a(+), the expressed protein was purified by two steps of Ni^2+ chelate affinity chromatography and anion exchange chromatography respectively. Use Western blot to identify the purified protein and vaccinated mice to test the antibody titer by indirect ELISA. ~Results : Recombinant expression plasmid pp65-pet32a was constructed successfully. The expressed protein existed in the form of inclusion body. Western blot analysis indicated protein had certain antigenicity. The mice can produce high titer antibody. Conclusion: High-level expression of pp65 was achieved in E.coli, the purified protein had strong immunoresponse. It indicated that expressed pp65 had a potential value for immunodiagnosis and immunotherapy. [
出处 《江苏大学学报(医学版)》 CAS 2004年第416期479-481,484,共4页 Journal of Jiangsu University:Medicine Edition
基金 上海市教委资助项目(04BA04)
关键词 人巨细胞病毒 PP65 表达纯化 蛋白质印迹法 ELISA Cytomegalovirus pp65 Expression and purification Western blot ELISA
  • 相关文献

参考文献2

  • 1Plotkin SA.Human cytomegalovirus vaccine is an orphan[J].Dev Biol (Basel),2002,110:73-80.
  • 2Akiyama Y,Maruyama K,Mochizuki T,et al.Identification of HLA-A24-restricted CTL epitope encoded by the matrix protein pp65 of human cytomegalovirus[J].Immunol Lett,2002,83(1):21-30.

同被引文献11

  • 1Wills MR, Carmichael AJ, Mynard K, et al. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequeney, specificity, and T-cell receptor usage of pp65-speeifie CTL[J]. J Virol, 1996,70:7569-7579.
  • 2Plotkin SA. Human cytomegalovirus vaccine is an orphan[J]. Dev Biol (Basel), 2002,110:73-80.
  • 3Cwynarski K, Ainsworth J, Cobbold M, et al. Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation[JI. Blood, 2001,97:1232-1240.
  • 4Gonczol E, Plotkin S. Development of a cytomegalovious vaccine:lessons from recent clinical trials[J]. Expert Opin Biol Ther,2001,1(3):401-412.
  • 5Brigitle S, Adam MB, John LR, et al. Infection of mature monocyte-derived dendritic ceils with human cytomegalovirus inhibits stimulation of T-cell proliferation via the release of solable CD83[J]. Blood, 2004.2:12.
  • 6Leung AK , Sauve RS , Davies HD. Congenital cytomegalovirus infection[J]. J Natl Med Assoc, 2003,95(3):213-218.
  • 7Hermann E, Holger H. CMV-speeific immunotherapy[J]. Human lmmunol, 2004,65(5):558-564.
  • 8Riddell SR, Watanaba KS, Goodrich JM, et al. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones[J]. Science, 1992,257(5067):238-241.
  • 9Andre-Sehmutz I, Dal Cortivo L, Hamel Y, et al. Gene transfer for activation of CMV specific T cells[J]. Human Immuncl, 2004.65(5):565-570.
  • 10Foster AE, Gottlieb D J, Macangolo M, et al. Rapid, large-scale generation of highly pure cytomegalovirus-specific cytotoxic T cells for adoptive immunotherapy[J]. J Hematother Stem Cell Res,2003,32(l):93-105.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部